Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The pulmonary pathology of COVID-19
Hans Bösmüller, Matthias S. Matter, Falko Fend, et al.
Virchows Archiv (2021) Vol. 478, Iss. 1, pp. 137-150
Open Access | Times Cited: 168

Showing 1-25 of 168 citing articles:

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
Felice D’Agnillo, Kathie‐Anne Walters, Yongli Xiao, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Open Access | Times Cited: 201
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19
James P. Bridges, Eszter K. Vladar, Hua Huang, et al.
Thorax (2021) Vol. 77, Iss. 2, pp. 203-209
Open Access | Times Cited: 137
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García‐Montero, Oscar Fraile‐Martínez, Coral Bravo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 106
Zinc Deficiency Associated With an Increase in Mortality in COVID-19 Patients: A Meta-Analysis
Chirag Raval, Spencer Z Rheingold, Antonio M. Gordon, et al.
Cureus (2025)
Open Access | Times Cited: 3
Hamster models of COVID-19 pneumonia reviewed: How human can they be?
Achim D. Gruber, Theresa C. Firsching, Jakob Trimpert, et al.
Veterinary Pathology (2021) Vol. 59, Iss. 4, pp. 528-545
Open Access | Times Cited: 68
Long-term Lung Abnormalities Associated with COVID-19 Pneumonia
Jeffrey P. Kanne, Brent P. Little, Jefree J. Schulte, et al.
Radiology (2022) Vol. 306, Iss. 2
Open Access | Times Cited: 62
Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt
Ahmed Ismail, Ahmed S. Doghish, Walid F. Elkhatib, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0271271-e0271271
Open Access | Times Cited: 51
Advances in 3D bioprinting for regenerative medicine applications
Konstantinos Loukelis, Nikos Koutsomarkos, Antonios G. Mikos, et al.
Regenerative Biomaterials (2024) Vol. 11
Open Access | Times Cited: 14
Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain
Airah Javorsky, Patrick O. Humbert, Marc Kvansakul
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 53
Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury
Astrid Obermayer, Lisa-Maria Jakob, Jasmin D. Haslbauer, et al.
Disease Markers (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 46
Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19
Luke Milross, Joaquim Majó, Nigel Cooper, et al.
The Lancet Respiratory Medicine (2021) Vol. 10, Iss. 1, pp. 95-106
Open Access | Times Cited: 43
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?
Danny Jonigk, Christopher Werlein, Till Acker, et al.
Virchows Archiv (2022) Vol. 481, Iss. 2, pp. 139-159
Open Access | Times Cited: 38
The Optimal Strategies to Be Adopted in Controlling the Co-Circulation of COVID-19, Dengue and HIV: Insight from a Mathematical Model
Andrew Omame, Aeshah A. Raezah, Uchenna Diala, et al.
Axioms (2023) Vol. 12, Iss. 8, pp. 773-773
Open Access | Times Cited: 19
Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers
David D. McFadden, Shari L. Bornstein, Robert Vassallo, et al.
Journal of Primary Care & Community Health (2022) Vol. 13
Open Access | Times Cited: 25
Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19
Keyla Santos Guedes de Sá, Luana A. Amaral, Tamara Silva Rodrigues, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012222-e1012222
Open Access | Times Cited: 6
Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses
Sayaka Nagasawa, Yuichiro Hirata, Shô Miyamoto, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0287068-e0287068
Open Access | Times Cited: 5
The Right Ventricle in COVID-19
Jean Bonnemain, Zied Ltaief, Lucas Liaudet
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2535-2535
Open Access | Times Cited: 28
Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian Hamsters
Kathleen R. Mulka, Sarah E. Beck, Clarisse V. Solis, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 195-207
Open Access | Times Cited: 28
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
Tobias Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 1, pp. 38-49
Open Access | Times Cited: 22
Understanding the mechanisms for COVID-19 vaccine’s protection against infection and severe disease
Huijie Yang, Ying Xie, Changgui Li
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 186-192
Open Access | Times Cited: 13
An agent-based modeling approach for lung fibrosis in response to COVID-19
Mohammad Aminul Islam, Michael Getz, Paul Macklin, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 12, pp. e1011741-e1011741
Open Access | Times Cited: 13
Organotypic lung tissue culture as a preclinical model to study host- influenza A viral infection: A case for repurposing of nafamostat mesylate
Pelin Sağlam-Metiner, Ece Yıldız-Ozturk, Aslı Tetik-Vardarli, et al.
Tissue and Cell (2024) Vol. 87, pp. 102319-102319
Closed Access | Times Cited: 4
SARS-CoV-2 Spike Protein Induces Oxidative Stress and Senescence in Mouse and Human Lung
Joel S. Greenberger, Wen‐Chi Hou, Donna Shields, et al.
In Vivo (2024) Vol. 38, Iss. 4, pp. 1546-1556
Open Access | Times Cited: 4
Enhanced complement activation and MAC formation accelerates severe COVID-19
Calder Ellsworth, Zhen Chen, Mark Xiao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19
Satyavani Kaliamurthi, Gurudeeban Selvaraj, Chandrabose Selvaraj, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7071-7071
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top